Fighting Cancer with Light

Researchers have developed a way to activate cancer fighting drugs by pulsing them with light, which could make such therapies safer.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Laser used for light-activated cancer therapyWIKIMEDIA COMMONS, NATIONAL CANCER INSTITUTE

Researchers have demonstrated a way to selectively target cancer cells for destruction—light. Researchers from the National Cancer Institute in Maryland used an antibody that targets proteins expressed on cancer cells to target tumors, and tagged it with a chemical that, when hit with a certain wavelength of near infrared light, becomes toxic to cells, according to the paper published Sunday (November 6) in Nature Medicine. By waiting until the antibody had bound to tumor cells before exposing it to infrared radiation, the researchers could effectively target just the cancer, and not the surrounding healthy tissue.

Importantly, the treatment was effective. The tumors of treated mice shrank significantly, with minimal damage to normal cells. Treated mice also lived significantly longer than controls, BBC News reported.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems